ZNF512 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.782370E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.831200E-01
Normal-vs-Stage2
8.602800E-03
Normal-vs-Stage3
5.582300E-02
Normal-vs-Stage4
3.145800E-01
Stage1-vs-Stage2
4.899600E-02
Stage1-vs-Stage3
3.860100E-03
Stage1-vs-Stage4
4.206200E-01
Stage2-vs-Stage3
8.502400E-02
Stage2-vs-Stage4
4.112600E-01
Stage3-vs-Stage4
5.000100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.476100E-02
Normal-vs-AfricanAmerican
1.075050E-01
Normal-vs-Asian
2.487200E-01
Caucasian-vs-AfricanAmerican
9.512200E-01
Caucasian-vs-Asian
3.499600E-01
AfricanAmerican-vs-Asian
4.354400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.857880E-02
Normal-vs-Female
2.612400E-02
Male-vs-Female
9.009000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.257000E-01
Normal-vs-Age(41-60Yrs)
3.677200E-01
Normal-vs-Age(61-80Yrs)
2.169700E-02
Normal-vs-Age(81-100Yrs)
2.443800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.157200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.420840E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.652320E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.028100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.248100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.567800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.196230E-02
Normal-vs-Daily Drinker
2.780200E-02
Normal-vs-Weekly Drinker
2.309800E-02
Normal-vs-Occasional Drinker
1.474990E-01
Normal-vs-Social Drinker
2.886800E-01
Non Drinker-vs-Daily Drinker
9.999600E-01
Non Drinker-vs-Weekly Drinker
7.551200E-01
Non Drinker-vs-Occasional Drinker
3.446600E-01
Non Drinker-vs-Social Drinker
3.694500E-02
Daily Drinker-vs-Weekly Drinker
7.840200E-01
Daily Drinker-vs-Occasional Drinker
4.080800E-01
Daily Drinker-vs-Social Drinker
6.706400E-02
Weekly Drinker-vs-Occasional Drinker
3.360600E-01
Weekly Drinker-vs-Social Drinker
5.749900E-02
Occasional Drinker-vs-Social Drinker
3.880000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.640300E-02
Normal-vs-Grade 2
4.717600E-03
Normal-vs-Grade 3
1.118010E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.134000E-01
Grade 1-vs-Grade 3
8.453200E-01
Grade 1-vs-Grade 4
6.640300E-02
Grade 2-vs-Grade 3
4.536000E-01
Grade 2-vs-Grade 4
4.717600E-03
Grade 3-vs-Grade 4
1.118010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.902400E-03
Normal-vs-NonDiabetic
2.767500E-02
Diabetic-vs-NonDiabetic
4.200300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.347600E-01
Normal-vs-NoPancreatitis
1.402310E-02
Pancreatitis-vs-NoPancreatitis
1.052640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.045560E-01
Normal-vs-N1
7.618500E-03
N0-vs-N1
1.662030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.464000E-01
Normal-vs-TP53-NonMutant
1.818790E-01
TP53-Mutant-vs-TP53-NonMutant
1.355440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
